Great West Life Assurance CO Cyma Bay Therapeutics, Inc. Transaction History

Great West Life Assurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $59,491 - $96,522	5,478 Added 185.95%	8,424 $126,000
Q2 2023 Aug 10, 2023	SELL	$7.47 - $10.95 $12,370 - $18,133	-1,656 Reduced 35.98%	2,946 $32,000
Q1 2023 May 12, 2023	BUY	$5.88 - $9.59 $27,059 - $44,133	4,602 New	4,602 $40,000
Q2 2021 Aug 11, 2021	SELL	$3.94 - $4.92 $13,187 - $16,467	-3,347 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.73 - $9.03 $19,178 - $30,223	3,347 New	3,347 $19,000
Q2 2020 Aug 17, 2020	SELL	$1.41 - $4.25 $4,605 - $13,880	-3,266 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$1.33 - $5.93 $4,343 - $19,367	3,266 New	3,266 $6,000
Q3 2019 Oct 25, 2019	SELL	$5.12 - $7.21 $58,275 - $82,064	-11,382 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$6.05 - $13.66 $30,855 - $69,666	5,100 Added 81.18%	11,382 $0
Q2 2018 Aug 10, 2018	BUY	$10.66 - $14.38 $66,966 - $90,335	6,282 New	6,282 $84,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.